Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patterns of Prescribing and Monitoring of Palbociclib

NCT03285568 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT03285568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03285568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patterns of Prescribing and Monitoring of Palbociclib
Lead sponsor
Rush University Medical Center
Phase
Observational
Overall status
Completed
Start date
February 3, 2015
Completion date
December 30, 2016
Enrollment
67 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer, estrogen receptor-positive breast cancer, human epidermal growth factor 2 negative carcinoma of breast, metastatic breast cancer